Serial Number
90823017
Owner
DxDiscovery, Inc.Attorney
Matthew D. FrancisFirst Use Date
Nov 30, 2015
Filing Date
Jul 12, 2021
DXDISCOVERY Trademark
Serial Number: 90823017 • Registration: 7469256
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
July 12, 2021
Registration Date
August 6, 2024
First Use Anywhere
November 30, 2015
First Use in Commerce
November 30, 2015
Published for Opposition
February 14, 2023
Goods & Services
Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, invasive candidiasis, Lyme disease, Pertussis, Cryptococcosis, Dermatophyte infection, Mucormycosis, Huanglongbing, and Bacillus anthracis (anthrax); Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Medical diagnostic reagents and assays for testing body fluids for microorganisms
Assays for research purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Pharmaceutical research and development; Research and development services in the field of antibodies; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of immunoassay; Research and development of vaccines and medicines; Scientific research and development; Vaccine research and development
